ECZEMA
Clinical trials for ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ECZEMA trials appear
Sign up with your email to follow new studies for ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Extended trial tests eczema Drug's Long-Term safety in kids
Disease control ENROLLING_BY_INVITATIONThis study aims to learn about the long-term safety and effectiveness of the drug lebrikizumab for children and teenagers with moderate-to-severe eczema. It is an extension study for up to 116 weeks, enrolling about 310 participants aged 6 months to under 18 years who completed a…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug trial aims to tame severe childhood eczema
Disease control OngoingThis study is testing an investigational drug called lebrikizumab in children and teenagers with moderate-to-severe eczema. Participants are randomly assigned to receive either the drug or a placebo to see if it improves their skin condition and reduces itching. The main goals ar…
Matched conditions: ECZEMA
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Baby skin cream trial aims to stop food allergies before they start
Prevention OngoingThis study is testing whether a special skin care routine for babies with early eczema can prevent them from developing food allergies. Researchers are comparing two approaches: a proactive treatment using a barrier cream and a mild steroid versus standard reactive care. The goal…
Matched conditions: ECZEMA
Phase: PHASE2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated Mar 27, 2026 12:40 UTC